Clinical Working Party of the European Society of Immunodeficiencies
Octapharma is thrilled to participate in the ESID 2021 online symposium on the immunological consequences of targeted immune therapies #ESID2021. During our sponsored symposium, our speakers discuss about "Secondary Immunodeficiencies in Haematological Malignancies".
Scroll down and click on each session to watch it on demand.
This scientific information may include data/information on investigational uses of compounds/drugs that have not yet been approved by regulatory authorities. This program was developed for use outside the U.S., is intended for non-U.S. HCPs, and is to be used in accordance with local laws and regulations.